[1] LEVEY A S, GANSEVOORT R T, CORESH J, et al. Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration with the US Food and Drug Administration and European Medicines Agency[J]. Am J Kidney Dis,2020,75(1): 84-104. [2] FLOEGE J, BARBOUR S J, CATTRAN D C, et al. Management and treatment of glomerular diseases(part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney Int,2019,95(2):268-280. [3] HEMMELGARN B R, MANNS B J, LIOYD A, et al. Relation between kidney function, proteinuria, and adverse outcomes[J]. JAMA, 2010, 303(5): 423-429. [4] LEVEY A S, CORESH J. Chronic kidney disease[J]. Lancet,2012, 379(9811): 165-180. [5] 国家老年医学中心,中国老年保健医学研究会老龄健康服务与标准化分会,《中国老年保健医学》杂志编辑委员会.老年人糖尿病前期干预指南[J].中国老年保健医学,2018,16(3):23-24. [6] WHEITION P K, CAREY R M, ARONOW W S, et al. 2017 ACC/AHA/AAPA /ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention,detection valuation,and management of high blood pressure in adults[J]. Hypertension, 2018,71(6): 1269-1324. [7] 诸骏仁,高润霖,赵水平,等. 中国成人血脂异常防治指南(2016年修订版) [J].中华全科医师杂志,2017,16(1):15-35. [8] 韦存胜,徐俊. 慢性肾脏病相关认知障碍研究进展[J] 实用老年医学,2014,28(7):536-539. [9] LESLEY A, MORGAN E, GRAMS A S, et al. Relationship of estimated GFR and albuminuria to concurrent laboratory abnormalities: An Individual Participant Data Metaanalysis in a Global Consortium[J]. Am J Kidney Dis, 2019,73(2): 206-217. [10] VANDER VELDE M, HABESMA N, CHARRO F T, et al. Screening for albuminuria identifies individuals at increased renal risk[J]. J Am Soc Nephrol, 2009, 20(4):852-862. |